NEOS Investments Announces August 2026 ETF Suite Distributions
NEOS Investments, an asset management firm comprised of leaders and pioneers in the options-based ETF space, announces August monthly distribution amounts for t
R - Ryder System, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$294.17
DETAILS
HIGH:
$320.00
LOW:
$245.00
MEDIAN:
$300.00
CONSENSUS:
$294.17
UPSIDE:
18.41%
Stock News
Ryder System Still Has Fuel In The Tank
Ryder System, Inc. remains a Buy as management drives revenue and profitability growth, with shares still trading at low multiples. Strategic focus on value-added services and shifting revenue mix toward SCS and DTS segments has doubled R's EPS and improved cash flow. FMS segment's ChoiceLease and SelectCare businesses offset rental softness, while fleet right-sizing and used-vehicle sales boost margins.
Theralase(R) Releases Q2 2026 Financial Statements
Theralase(R) Provides Updates on its Phase II Bladder Cancer Clinical Study and Oncology Pipeline Toronto, Ontario--(Newsfile Corp. - August 28, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical-stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of various cancers, bacteria and viruses, has released the Company's unaudited interim consolidated financial statements for the six-month period ended June 30th, 2026 ("Financial Statements"). Theralase® will be hosting a conference call on September 3rd at 11:00 am ET, which will include a presentation of the financial and operational results for the quarter ended June 30th, 2026.
3 Stocks to Watch From the Transport Equipment & Leasing Industry
Headwinds, including inflation, tariff-related tensions and lingering supply-chain disruptions, hurt the Zacks Transportation - Equipment and Leasing industry. WAB, AER and R are likely to stand out.
Smith-Midland Awarded $2.2M SlenderWall(R) Coast Guard Project
MIDLAND, VA / ACCESS Newswire / August 26, 2026 / Smith-Midland Corporation (NASDAQ:SMID), a leading manufacturer of innovative precast concrete products for transportation, infrastructure, and building construction, has been awarded a $2.2 million contract to manufacture and supply its SlenderWall® architectural precast wall system for the new U.S. Coast Guard Clinic and Visitors Center in Charleston, South Carolina, further expanding the company's portfolio of mission-critical government and military construction projects. The contract further strengthens Smith-Midland's position in the architectural precast market and demonstrates demand for SlenderWall® on complex institutional and government projects.
Ryder 2026 E-commerce Consumer Study: New Trends Emerge as 64% of Shoppers Adopt AI; Expectations Evolve Beyond Price
MIAMI--(BUSINESS WIRE)-- #Ecommercefulfillment--Ryder System, Inc. (NYSE: R) today published its 12th annual benchmark study of U.S. consumer online shopping behaviors, preferences, and expectations, “Beyond Price: What's Driving Consumer Shopping Behavior.” The study examines how consumers balance convenience, cost, and experience, providing brands and retailers with actionable insights to refine their e-commerce and omnichannel fulfillment strategies in an increasingly complex retail landscape. Download the full Ryd.
Algert Global LLC Sells 8,840 Shares of Ryder System, Inc. $R
Algert Global LLC lowered its holdings in shares of Ryder System, Inc. (NYSE: R) by 14.7% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 51,455 shares of the transportation company's stock after selling 8,840 shares during the period. Algert Global LLC
Jackpot Digital Launches Two Jackpot Blitz(R) ETGs at Inn of the Mountain Gods Resort & Casino
Vancouver, British Columbia--(Newsfile Corp. - August 25, 2026) - Jackpot Digital Inc. (TSXV: JJ) (OTCQB: JPOTF) (Frankfurt Stock Exchange: LVH3) (the "Company" or "Jackpot Digital"), the world's leading provider of innovative dealerless electronic poker gaming tables, is pleased to announce the successful installation of two Jackpot Blitz® dealerless poker electronic table games ("ETGs") at Inn of the Mountain Gods Resort & Casino ("Inn of the Mountain Gods"), a Mescalero Apache Tribe-owned property located in Mescalero, New Mexico. Jackpot Blitz® is an advanced, fully automated casino poker table that replaces the need for traditional live dealers, delivering faster gameplay, operational efficiency, and an engaging experience for players.
Callan Family Office LLC Acquires New Stake in Ryder System, Inc. $R
Callan Family Office LLC bought a new position in shares of Ryder System, Inc. (NYSE: R) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,079 shares of the transportation company's stock, valued at approximately $812,000. A
Theralase(R) Closes C$3.6 Million Brokered Financing
Toronto, Ontario--(Newsfile Corp. - August 24, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria and viruses, is pleased to announce that it has closed its previously announced brokered private placement offering ("Offering"), pursuant to which the Company issued 14,812,500 units ("Units") at a price of C$0.24 per Unit ("Offering Price") for aggregate gross proceeds of C$3,555,000. The Offering was led by Research Capital Corporation as sole agent and sole bookrunner ("Agent").
Deutsche Bank AG Makes New $15.27 Million Investment in Ryder System, Inc. $R
Deutsche Bank AG acquired a new stake in Ryder System, Inc. (NYSE: R) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 57,877 shares of the transportation company's stock, valued at approximately $15,266,000. Deutsche Bank AG owned approximately 0.15%
BlackRock Inc. Purchases Shares of 4,021,493 Ryder System, Inc. $R
BlackRock Inc. purchased a new stake in Ryder System, Inc. (NYSE: R) in the undefined quarter, according to its most recent filing with the SEC. The institutional investor purchased 4,021,493 shares of the transportation company's stock, valued at approximately $1,060,749,000. BlackRock Inc. owned approximately 10.49% of Ryder System at the end of the
7,571 Shares in Ryder System, Inc. $R Acquired by Advisors Preferred LLC
Advisors Preferred LLC purchased a new stake in Ryder System, Inc. (NYSE: R) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 7,571 shares of the transportation company's stock, valued at approximately $1,974,000. A number of other institutional investors and hedge funds
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Letter of Intent with Darmiyan, Inc. to Explore Use of FDA De Novo Authorized BrainSee(R) AI Platform in Early Alzheimer's Disease Trial Design
Collaboration looks to explore the use of Darmiyan's FDA De Novo authorized BrainSee® imaging platform, authorized for predicting risk of progression to Alzheimer's disease in patients with amnestic mild cognitive impairment, as well as Darmiyan's core technology, the Virtual Microscope, tailored towards use in pharmaceutical clinical trials The goal of the collaboration is to inform the identification, selection and monitoring of the best candidates for clinical trials of PEX010, Rhelion's patented, naturally derived psilocybin drug candidate Toronto, Ontario--(Newsfile Corp. - August 20, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX) (OTCQB: TRUFF) ("Rhelion" or the "Company"), an Ontario-based organization advancing innovation and research within the legal psychedelic sector, is pleased to announce that its wholly owned subsidiary, Filament Health Corp. ("Filament"), has entered into a non-binding letter of intent (the "LOI") with Darmiyan, Inc. ("Darmiyan"), a San Francisco based brain technology company, to explore a collaboration combining Darmiyan's artificial intelligence brain imaging platform with PEX010, Filament's patented, standardized, GMP manufactured natural psilocybin drug candidate. Darmiyan is the developer of BrainSee, which in January 2024 received marketing authorization from the U.S. Food and Drug Administration ("FDA") through the De Novo pathway, following the granting of FDA Breakthrough Device Designation in 2021.
Everest Medicines Reports 1H 2026 Results, Enters New Phase as Growth Accelerates and Innovation Gains Momentum
HONG KONG, Aug 19, 2026 - (ACN Newswire) - Everest Medicines (01952.HK) announced its interim results for the six months ended June 30, 2026. Everest delivered
Ryder Honors 2026 Top Technician at 25th Anniversary Skills Competition
MIAMI--(BUSINESS WIRE)--Jean-Sébastien Houle of Boucherville, Quebec, has been named Ryder's 2026 Top Technician, earning the $50,000 grand prize at the company's 25th annual Top Tech Skills Competition, one of Ryder's premier recognition programs honoring the company's most skilled commercial truck technicians. “Congratulations to Jean-Sébastien on earning the 2026 Top Tech title. We also extend our gratitude to all the finalists for their incredible expertise and skills,” says John Diez, chie.
Ryder System, Inc. $R Shares Sold by Empowered Funds LLC
Empowered Funds LLC lessened its position in shares of Ryder System, Inc. (NYSE: R) by 93.6% during the undefined quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,239 shares of the transportation company's stock after selling 47,667 shares during the quarter. Empowered Funds LLC's
Stakeholder Gold Upgrades to OTCQX(R) Best Market
Toronto, Ontario--(Newsfile Corp. - August 17, 2026) - Stakeholder Gold Corp. (TSXV: SRC) (OTCQX: SKHRF) (WKN: A2QEP1) is pleased to announce that the Company has qualified to trade on the OTCQX® Best Market in the United States and has commenced trading today under the symbol "SHKRF". The Company has upgraded to the OTCQX® from the OTCQB® Venture Market.
CanSinoBIO's NDA for Td5cp Adolescent and Adult Accepted, Further Strengthening Its Diversified Vaccine Pipeline
HONG KONG, Aug 16, 2026 - (ACN Newswire) - On August 16, 2026, CanSino Biologics Inc. ("CanSinoBIO"; HKEX: 06185/SHSE: 688185) announced that the New Drug Appli
Dividend Champion, Contender, And Challenger Highlights: Week August 16
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Price Targets
Ryder price target raised to $300 from $290 at Barclays
$300.00
(was $260.13)
Brandon Oglenski
·
Barclays
Ryder price target raised to $320 from $280 at Morgan Stanley
$320.00
(was $270.56)
Ravi Shanker
·
Morgan Stanley
Ryder price target raised to $310 from $290 at Susquehanna
$310.00
(was $264.25)
Susquehanna
Ryder price target raised to $300 from $290 at Wells Fargo
$300.00
(was $267.91)
Wells Fargo
Ryder price target raised to $280 from $263 at Morgan Stanley
$280.00
(was $265.39)
Morgan Stanley
Ryder price target raised to $290 from $250 at Barclays
$290.00
(was $261.01)
Brandon Oglenski
·
Barclays
Ryder price target raised to $290 from $253 at Baird
$290.00
(was $274.66)
Robert W. Baird
Ryder price target raised to $290 from $260 at Wells Fargo
$290.00
(was $264.96)
Robert Salmon
·
Wells Fargo
Ryder price target raised to $245 from $219 at Goldman Sachs
$245.00
(was $242.59)
Jordan Alliger
·
Goldman Sachs
Ryder price target raised to $253 from $202 at Baird
$253.00
(was $242.59)
Daniel Moore
·
Robert W. Baird
Ryder price target raised to $250 from $220 at Barclays
$250.00
(was $242.59)
Barclays
Ryder price target raised to $219 from $197 at Goldman Sachs
$219.00
(was $211.97)
Goldman Sachs
Ryder price target raised to $250 from $235 at Susquehanna
$250.00
(was $208.01)
Harrison Bauer
·
Susquehanna
Ryder price target raised to $236 from $210 at Wells Fargo
$236.00
(was $217.31)
Wells Fargo
Ryder price target raised to $250 from $190 at Morgan Stanley
$250.00
(was $186.39)
Ravi Shanker
·
Morgan Stanley
Ryder initiated with an Overweight at Wells Fargo
$210.00
(was $180.01)
Wells Fargo
Ryder price target raised to $220 from $190 at Barclays
$220.00
(was $189.95)
Barclays
Ryder price target raised to $155 from $140 at Baird
$155.00
(was $132.00)
Garrett Holland
·
Robert W. Baird
Ryder initiated with an Overweight at Morgan Stanley
$165.00
(was $121.00)
Christyne McGarvey
·
Morgan Stanley
Ryder upgraded to Buy on higher estimates at Vertical Research
$145.00
(was $120.19)
Jeffrey Kauffman
·
Vertical Research